Background 34 The application of polymeric materials in medical industry has grown drastically in the last 35 two decades due to their various advantages compared to existing materials. The present 36 research work emphases on the sol-gel technique to formulate the polymethyl methyl 37 acrylate/polystyrene/silica composite membrane.
Figure 1
The mechanism of interaction that occurs between PS and PMMA 109 110
Based on the literature survey and to the best of our knowledge we are the first to 111 report about the combination of PMMA/PS/Si composite material for medical application. 112 The silica was selected as filler material due to its biocompatibility and ease availability in 113 nature. There were quite an enormous amount of research that have been conducted with 114 silica based polymeric materials for biomedical applications such as implants and artificial 115 skin [18, 19] . Apart from its biocompatibility nature, its incorporation also increase the 116 strength of polymeric materials and influence the creation of apatite formation thereby 117 enhancing the bioactivity of composite by interacting with negatively charged silanol and 118 SBF solution. In the present study, PMMA/PS/Si composite membranes were prepared in 119 different weight ratios of PMMA and PS (1:1, 1:2, 2:1) with constant weight of silica. The 120 prepared composite membranes were tested for its bioactivity by immersing in SBF and 121 cytotoxicity studies by MTT method. 
Materials and Methods

124
The materials that were used for the study were procured commercially from different 125 sources. PMMA (Mol. Wt 35,000 Da) was procured from Asian acrylates, Mumbai, 126 Polystyrene from Sigma Aldrich. Silica and Tetraethyl orthosilicate (TEOS, 99.5% pure) 127 were purchased from Sigma Aldrich. THF, Hydrochloric acid was purchased from Merck. 128 Different polymer system employed and their corresponding code, weight ratio is shown in 129 The polymer silica composite membranes were prepared by weighing different amounts of 133 PMMA and Polystyrene in separate beakers followed by dissolving in THF solvent. The 134 polymers solutions were mixed together with constant stirring to form PMMA/PS blends.
135
The silica particles as mentioned in Table 1 were added to the homogenous polymer solution 136 and subsequently stirred, ultra-sonicated for 2 hours to get uniform dispersion of silica 137 particles. In order to enhance the gelation process 0.25 ml of 35% HCl, 5 ml ethanol and 1ml 138 of tetra ethoxy silane (TEOS) were added to the polymer solution. The solutions were left for 139 three days stirring to complete the gelation process. The gel obtained was then casted onto 140 clean-dried petri dishes and left undisturbed for three days at room temperature. After 141 complete removal of solvent, the membranes were removed from the petri dish for the further 142 analysis.
144
Fourier Transform Infra-Red Spectroscopy (FTIR) 145 The presence and interaction of different functional groups in polymers were studied using 146 FTIR. The composite membranes of PMMA/PS prepared were characterized using Perkin 147 Elmer Spectrum RXI IR spectrophotometer.
149
Scanning Electron Microscope (SEM) 150 The surface morphology and dispersion of silica fillers in the prepared composite membranes 151 were studied using HITACHI S-3400N Scanning Electron Microscope (SEM). Prior to the 152 analysis, the samples were dried and their surface was gold sputtered. previous studies [20] . The study was carried out by immersing pre-weighed dried membranes 157 in deionized water on a glass beaker for 24 hours. After 24 hours, wet membranes were 158 retrieved from the beaker and excess water was blotted gently using a tissue paper. The wet samples were again weighed, and the water absorption percentage was calculated using the Biocompatibility test 185 The composites prepared must be biocompatible such that it can be applied in vivo. Hence, in 186 the present study we used MTT assay to quantify the biocompatibility of prepared In vitro inflammatory studies 195 We have evaluated the inflammatory response of PMMA-PS composited using RAW 264.7 196 macrophage cells in vitro. The cells were tested with composite prepared and inflammatory 197 responses for cytokines TNF-α, IL-6 and IL-1were checked using qPCR. Briefly, the cells 198 were treated with the samples and allowed for 6h incubation. The first inflammatory response 199 was analyzed by extracting the RNA and reverse transcribing the same to form cDNA.
200
Followed by the analyzing of expression of inflammatory markers using qPCR. The blend containing 1:1 ratio showed characteristic absorption peaks of PMMA 215 corresponding to asymmetric stretching of CH 3 and C=O were assigned to bands 2951 cm -1 216 and 1736 cm -1 ( Figure 2 ). The peaks 1482 cm -1 is a characteristic vibrational band for CH 2 217 scissoring, similarly the vibrational band at 1452 cm -1 corresponding to asymmetric vibration 218 of CH 3 stretching or due to the PMMA deformation which was further confirmed by OCH 3 219 deformation peaks at 1390 cm -1 ( Figure 2 ). In addition, the absorption peaks at 1600 and 698 220 cm -1 in all the blends represents the C-C stretching and ring deformation of polystyrene. The 221 broadened peaks at 750, 1050 and 1200 were observed for blend of 1:1 which are correspond 222 to CH 2 twisting, wagging and rocking respectively, whereas the blend of 2:1 and 1:2 appeared to be smooth curve in the same region [24] . The IR results confirm that the blend 224 was strongly mixed and formation of polymer blends in case of equal concentration of 225 polymer compared to other two concentrations. It was observed that the results were in par 226 with other reports and confirmed that there was no major shift in the peaks hence the blends 227 may be due to physical bonding rather than a chemical one [25] . The results of the water absorption studies for the three groups is shown in Figure 3 . The composites prepared for applying as bone cement was checked for its effective drug 285 release kinetics as it may serve for multipurpose in enhancing the bone growth with active 286 release of drug ( figure 7) . It was observed from drug release kinetics that the drug was 287 released in a sustained manner for a period of 180 h in PBS at pH 6.8. The initial phase or 288 burst release was observed in all three cases the models that is in par with other research reports [26] [27] [28] [29] . It has to be noted that the drug release in model 1 may be due to fickian 290 diffusion and took a very long time owing to higher concentration & hydrophilic nature of 291 PMMA that makes the drug release in a much-sustained fashion. This was not the case with composite did not fit into any other models, which is out of the scope of our study.
306
In vitro Cytotoxicity by MTT method 307 The cytotoxicity studies performed showed interesting results. Figure 8 shows the RAW The results were in par when studied with MTT assay where the composites with equal 317 concentration of polymers showed an enhanced viability compared to the other two models.
318
The percentage viability of the cells was calculated after noting the OD values of the control.
319
The results are displayed in figure 9 in which a graph is plotted by taking the cell count of the bearing orthopedic applications but more suited for sustained drug delivery and tissue 368 engineering application. Model 1 showed very good tensile properties whereas other two 369 models showed optimum biocompatibility and moderate strength that shall be suitable 370 orthopedic application. 
